Trial Summary
What is the purpose of this trial?
This trial studies how well magnetic resonance imaging (MRI)-guided internal radiation therapy (brachytherapy) works in treating participants with human papillomavirus (HPV) associated stage IB2-IV cervical or stage II-IVA vaginal cancer. Using MRI guidance during brachytherapy applicator placement may improve treatment planning in participants with cervical or vaginal cancer.
Research Team
AH
Ann H. Klopp
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for women with stage IB2-IVA cervical cancer or stage II-IVA vaginal cancer, recommended to receive chemoradiation including brachytherapy. It's not suitable for those with non-MRI-compatible anatomy, pacemakers, defibrillators, or conditions that prevent MRI use.Inclusion Criteria
Women with advanced stage cervical cancer who are recommended to receive a specific type of treatment called chemoradiation, including brachytherapy.
Women with a specific stage of vaginal cancer who are advised to undergo a specific type of treatment involving chemotherapy and radiation therapy.
Exclusion Criteria
Patient or tumor anatomy that requires use of a non-MRI-compatible applicator
Patients with implantable cardioverter-defibrillator, pacemaker or other implanted device or medical condition which precludes MRI acquisition.
Treatment Details
Interventions
- Internal Radiation Therapy (Brachytherapy)
- MRI-Guided Brachytherapy (Procedure)
Trial OverviewThe study tests if using MRI guidance to place the internal radiation therapy device (brachytherapy) can improve treatment planning and outcomes in participants with HPV-associated cervical or vaginal cancers.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Treatment (MRI, internal radiation therapy)Experimental Treatment2 Interventions
Participants undergo MRI scan during internal radiation therapy applicator placement.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
M D Anderson Cancer CenterHouston, TX
Loading ...
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Trials
3107
Patients Recruited
1,813,000+
National Cancer Institute (NCI)
Collaborator
Trials
14080
Patients Recruited
41,180,000+